Responses
Scientific Abstracts
Poster Tours
AxSpA: About treatments and outcomes
POS0306 EFFICACY AND SAFETY OF UPADACITINIB IN PATIENTS WITH ACTIVE ANKYLOSING SPONDYLITIS REFRACTORY TO BIOLOGIC THERAPY: A DOUBLE-BLIND, RANDOMIZED, PLACEBO-CONTROLLED PHASE 3 TRIAL
Compose a Response to This Article
Other responses
No responses have been published for this article.